Catalyst Wire Dossier Catalyst Wire Dossier

Dabrafenib

Dabrafenib · Novartis
Drug timelines are a Plus or Pro feature.

61 regulatory and trial events tracked for Dabrafenib, covering 2014-03-05 to 2026-05-22. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Previously Treated Patients With Metastatic, Radio-active Iodine Refractory BRAF V600E Mutation Positive Differentiated Thyroid Cancer [Phase 3]

See pricing